​
​

AbCellera Biologics Ownership | Who Owns AbCellera Biologics?

OverviewForecastRevenueFinancialsChartTranscripts

AbCellera Biologics Ownership Summary

AbCellera Biologics is owned by 39.05% institutional investors, 27.99% insiders, and 32.96% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 9.40% of ABCL shares. Allianz Global Artfcl Intlgc W EUR is the top mutual fund, with 2.10% of its assets in AbCellera Biologics shares.

ABCL Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAbCellera Biologics39.05%27.99%32.96%
SectorHealthcare Stocks 47.25%8.01%44.75%
IndustryBiotech Stocks 45.35%7.81%46.83%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Allianz Global Artfcl Intlgc W EUR6.18M2.10%31.00K
Baillie Gifford Positive Change B Acc4.76M1.62%25.79K
Baillie Gifford Positive Change4.75M1.61%-
SMDS Global AI Equity Mother4.49M1.52%-
UBS (Lux) Digital Health Equity SB USD4.50M1.52%-
American Funds IS® Asset Allocation 12.87M0.97%-
Baillie Gifford WW Pstv Chg B USD Acc2.78M0.94%5.15K
American Funds SMALLCAP World A2.45M0.83%-3.03M
iShares Biotechnology ETF1.46M0.49%-8.71K
Lazard Digital Health1.04M0.35%60.06K

Recent Insider Transactions

DateNameRoleActivityValue
Aug 29, 2024Thermopylae Holdings Ltd.-Buy$739.98K
Nov 06, 2023Montalbano John S.-Buy$92.80K
Nov 08, 2023Montalbano John S.-Buy$44.60K
Sep 22, 2023Hayden Michael R-Buy$98.20K
Sep 12, 2023Lecault Veronique Chief Operating OfficerBuy$103.80K

Insider Transactions Trends

DateBuySell
2024 Q31-
2024 Q2--
2024 Q1--
2023 Q42-
2023 Q33-

ABCL Ownership FAQ

Who Owns AbCellera Biologics?

AbCellera Biologics shareholders are primarily institutional investors at 39.05%, followed by 27.99% insiders and 32.96% retail investors. The average institutional ownership in AbCellera Biologics's industry, Biotech Stocks , is 45.35%, which AbCellera Biologics falls below.

Who owns the most shares of AbCellera Biologics?

AbCellera Biologics’s largest shareholders are Baker bros. advisors lp (27.53M shares, 9.40%), Baillie gifford (21.91M shares, 7.49%), and Voya investment management (10.63M shares, 3.63%). Together, they hold 20.52% of AbCellera Biologics’s total shares outstanding.

Does Blackrock own AbCellera Biologics?

Yes, BlackRock owns 1.30% of AbCellera Biologics, totaling 3.8M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 11.26M$. In the last quarter, BlackRock decreased its holdings by -97.087K shares, a -2.49% change.

Who is AbCellera Biologics’s biggest shareholder by percentage of total assets invested?

Prosight management, lp is AbCellera Biologics’s biggest shareholder by percentage of total assets invested, with 2.08% of its assets in 2.35M AbCellera Biologics shares, valued at 6.96M$.

Who is the top mutual fund holder of AbCellera Biologics shares?

Allianz Global Artfcl Intlgc W EUR is the top mutual fund holder of AbCellera Biologics shares, with 2.10% of its total shares outstanding invested in 6.18M AbCellera Biologics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools